- Home
- WKEY vs CRVO Comparison
WKEY vs CRVO Comparison
Compare WKEY & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKEY
- CRVO
- Stock Information
- Founded
- WKEY 1999
- CRVO 2001
- Country
- WKEY Switzerland
- CRVO United States
- Employees
- WKEY N/A
- CRVO N/A
- Industry
- WKEY EDP Services
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- WKEY Technology
- CRVO Health Care
- Exchange
- WKEY Nasdaq
- CRVO Nasdaq
- Market Cap
- WKEY 78.1M
- CRVO 71.0M
- IPO Year
- WKEY N/A
- CRVO N/A
- Fundamental
- Price
- WKEY $6.41
- CRVO $7.12
- Analyst Decision
- WKEY Strong Buy
- CRVO Strong Buy
- Analyst Count
- WKEY 1
- CRVO 8
- Target Price
- WKEY $4.00
- CRVO $25.57
- AVG Volume (30 Days)
- WKEY 245.2K
- CRVO 142.9K
- Earning Date
- WKEY 06-24-2025
- CRVO 08-08-2025
- Dividend Yield
- WKEY N/A
- CRVO N/A
- EPS Growth
- WKEY N/A
- CRVO N/A
- EPS
- WKEY N/A
- CRVO N/A
- Revenue
- WKEY $11,875,000.00
- CRVO $9,308,215.00
- Revenue This Year
- WKEY $18.18
- CRVO N/A
- Revenue Next Year
- WKEY $112.51
- CRVO N/A
- P/E Ratio
- WKEY N/A
- CRVO N/A
- Revenue Growth
- WKEY N/A
- CRVO 15.14
- 52 Week Low
- WKEY $1.61
- CRVO $1.80
- 52 Week High
- WKEY $14.00
- CRVO $22.57
- Technical
- Relative Strength Index (RSI)
- WKEY 52.16
- CRVO 38.60
- Support Level
- WKEY $6.12
- CRVO $7.20
- Resistance Level
- WKEY $8.11
- CRVO $8.30
- Average True Range (ATR)
- WKEY 0.61
- CRVO 0.62
- MACD
- WKEY -0.08
- CRVO -0.03
- Stochastic Oscillator
- WKEY 24.44
- CRVO 7.50
About WKEY WISeKey International Holding Ltd
WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.